Q2 2025 Highlights Backlog of $4.6 billion at quarter-end, provides revenue visibility for 2025 Revenues of $373.3 million, up 54% YoY Adjusted EBITDA1 of $76.3 million, up 57% YoY, and adjusted EBITDA margin1 of 20.4% Adjusted net income1 of $48.1 million, up 106% YoY, and adjusted...
Related Questions
Are there any planned capital expenditures or reinvestments that could materially affect free cash flow or margins?
What is the expected conversion rate of the current backlog into actual revenue in the next quarters?
What specific factors drove the 57% increase in adjusted EBITDA and can they be expected to persist?
How does the adjusted EBITDA margin of 20.4% compare to MDA's historical margins and to peers in the sector?
Is the 54% year‑over‑year revenue growth sustainable given market demand and competitive pressures?
What is the outlook for adjusted net income beyond this quarter and what assumptions underpin it?
How will the $4.6 billion backlog at quarter‑end translate into revenue visibility and cash flow for the remainder of 2025?
How will the strong earnings results impact valuation multiples such as P/E and EV/EBITDA for the stock?
How does MDA's Q2 2025 performance stack up against its main competitors' results for the same period?
What macro‑economic or industry risks could threaten the continuation of this growth trajectory?